BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15816793)

  • 61. Association between maternal smoking and increased symptom severity in Tourette's syndrome.
    Mathews CA; Bimson B; Lowe TL; Herrera LD; Budman CL; Erenberg G; Naarden A; Bruun RD; Freimer NB; Reus VI
    Am J Psychiatry; 2006 Jun; 163(6):1066-73. PubMed ID: 16741208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM
    J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder.
    Miguel EC; do Rosário-Campos MC; Prado HS; do Valle R; Rauch SL; Coffey BJ; Baer L; Savage CR; O'Sullivan RL; Jenike MA; Leckman JF
    J Clin Psychiatry; 2000 Feb; 61(2):150-6; quiz 157. PubMed ID: 10732667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics.
    Petter T; Richter MA; Sandor P
    J Clin Psychiatry; 1998 Sep; 59(9):456-9. PubMed ID: 9771815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder.
    Miguel EC; Coffey BJ; Baer L; Savage CR; Rauch SL; Jenike MA
    J Clin Psychiatry; 1995 Jun; 56(6):246-55. PubMed ID: 7775367
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A placebo-controlled trial of risperidone in Tourette syndrome.
    Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
    Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder.
    Delgado PL; Goodman WK; Price LH; Heninger GR; Charney DS
    Br J Psychiatry; 1990 Nov; 157():762-5. PubMed ID: 2126219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quetiapine treatment of children and adolescents with Tourette's disorder.
    Mukaddes NM; Abali O
    J Child Adolesc Psychopharmacol; 2003; 13(3):295-9. PubMed ID: 14642017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reliability and validity of the Yale Global Tic Severity Scale.
    Storch EA; Murphy TK; Geffken GR; Sajid M; Allen P; Roberti JW; Goodman WK
    Psychol Assess; 2005 Dec; 17(4):486-91. PubMed ID: 16393016
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette's disorder.
    Zhao L; Li AY; Lv H; Liu FY; Qi FH
    J Int Med Res; 2010; 38(1):169-75. PubMed ID: 20233526
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeted Interventions in Tourette's using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette's syndrome.
    Kahl CK; Swansburg R; Kirton A; Pringsheim T; Wilcox G; Zewdie E; Harris A; Croarkin PE; Nettel-Aguirre A; Chenji S; MacMaster FP
    BMJ Open; 2021 Dec; 11(12):e053156. PubMed ID: 34952879
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.
    Peterson BS; Zhang H; Anderson GM; Leckman JF
    J Clin Psychopharmacol; 1998 Aug; 18(4):324-31. PubMed ID: 9690699
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder: a pilot randomised controlled trial with long-term follow-up.
    Andrén P; Aspvall K; Fernández de la Cruz L; Wiktor P; Romano S; Andersson E; Murphy T; Isomura K; Serlachius E; Mataix-Cols D
    BMJ Open; 2019 Feb; 9(2):e024685. PubMed ID: 30772854
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder.
    Coffey BJ; Biederman J; Geller DA; Spencer TJ; Kim GS; Bellordre CA; Frazier JA; Cradock K; Magovcevic M
    J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):556-61. PubMed ID: 10802972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.